{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T06:15:18Z","timestamp":1786947318319,"version":"build-2736575974"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"vor","delay-in-days":176,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["SNSF 32003B_189132 \/ 1"],"award-info":[{"award-number":["SNSF 32003B_189132 \/ 1"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 DA012393"],"award-info":[{"award-number":["P30 DA012393"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018234","name":"Inselspital, Universit\u00e4tsspital Bern","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018234","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018261","name":"Insel Hospital Group","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018261","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jpba.2025.116703","type":"journal-article","created":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T11:15:53Z","timestamp":1737976553000},"page":"116703","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["A validated single-step saliva and serum sample extraction LC-MS\/MS method for the analysis of nicotine, cotinine and 3\u2019-hydroxycotinine for clinical vaping studies"],"prefix":"10.1016","volume":"258","author":[{"given":"Vera","family":"van der Velpen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2239-1378","authenticated-orcid":false,"given":"Evangelia","family":"Liakoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mats B.","family":"Hirt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celina M.","family":"Vonwyl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3103-781X","authenticated-orcid":false,"given":"Samuel E.","family":"Christen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urs","family":"Duthaler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peyton","family":"Jacob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1846-8640","authenticated-orcid":false,"given":"Manuel","family":"Haschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"192","key":"10.1016\/j.jpba.2025.116703_bib1","first-page":"v","article-title":"Handbook of experimental pharmacology 192. Nicotine psychopharmacology","author":"Henningfield","year":"2009","journal-title":"Preface. Handb. Exp. Pharm."},{"issue":"192","key":"10.1016\/j.jpba.2025.116703_bib2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/978-3-540-69248-5_2","article-title":"Nicotine chemistry, metabolism, kinetics and biomarkers","author":"Benowitz","year":"2009","journal-title":"Handb. Exp. Pharm."},{"key":"10.1016\/j.jpba.2025.116703_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.addbeh.2023.107616","article-title":"Specific biomarker comparison in current smokers, e-cigarette users, and non-smokers","volume":"140","author":"Melero-Ollonarte","year":"2023","journal-title":"Addict. Behav."},{"issue":"14","key":"10.1016\/j.jpba.2025.116703_bib4","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1024\/1661-8157\/a003026","article-title":"Biomarkers of smoking - which cut-off values should be used?","volume":"107","author":"Gruber","year":"2018","journal-title":"Praxis"},{"issue":"5","key":"10.1016\/j.jpba.2025.116703_bib5","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/FPC.0000000000000427","article-title":"Effect of race and glucuronidation rates on the relationship between nicotine metabolite ratio and nicotine clearance","volume":"31","author":"Liakoni","year":"2021","journal-title":"Pharm. Genom."},{"issue":"9","key":"10.1016\/j.jpba.2025.116703_bib6","doi-asserted-by":"crossref","first-page":"e661","DOI":"10.1016\/S2468-2667(21)00106-7","article-title":"Prevalence of electronic nicotine delivery systems and electronic non-nicotine delivery systems in children and adolescents: a systematic review and meta-analysis","volume":"6","author":"Yoong","year":"2021","journal-title":"Lancet Public Health"},{"issue":"7","key":"10.1016\/j.jpba.2025.116703_bib7","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1056\/NEJMoa2308815","article-title":"Electronic nicotine-delivery systems for smoking cessation","volume":"390","author":"Auer","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jpba.2025.116703_bib8","unstructured":"GBD 2019 Tobacco Collaborators, Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990-2019: a systematic analysis from the Global Burden of Disease Study 2019, Lancet 397 (10292) (2021) 2337\u20132360."},{"issue":"4","key":"10.1016\/j.jpba.2025.116703_bib9","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.healthpol.2021.02.003","article-title":"Emerging electronic cigarette policies in European member states, Canada, and the United States","volume":"125","author":"Snell","year":"2021","journal-title":"Health Policy"},{"issue":"12","key":"10.1016\/j.jpba.2025.116703_bib10","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1080\/17425247.2020.1814736","article-title":"Nicotine forms: why and how do they matter in nicotine delivery from electronic cigarettes?","volume":"17","author":"Gholap","year":"2020","journal-title":"Expert Opin. Drug Deliv."},{"issue":"e1","key":"10.1016\/j.jpba.2025.116703_bib11","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.1136\/tobaccocontrol-2021-056626","article-title":"Synthetic nicotine has arrived","volume":"32","author":"Jordt","year":"2023","journal-title":"Tob. Control"},{"issue":"7","key":"10.1016\/j.jpba.2025.116703_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0220300","article-title":"Nicotine absorption during electronic cigarette use among regular users","volume":"14","author":"Yingst","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jpba.2025.116703_bib13","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jpba.2012.12.018","article-title":"On-line solid-phase extraction with ultra performance liquid chromatography and tandem mass spectrometry for the detection of nicotine, cotinine and trans-3\u2032-hydroxycotinine in urine to strengthen human biomonitoring and smoking cessation studies","volume":"76","author":"De Cremer","year":"2013","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"15","key":"10.1016\/j.jpba.2025.116703_bib14","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1002\/jssc.201300220","article-title":"A simple, fast, and sensitive method for the measurement of serum nicotine, cotinine, and nornicotine by LC\u2013MS\/MS","volume":"36","author":"Yuan","year":"2013","journal-title":"J. Sep. Sci."},{"key":"10.1016\/j.jpba.2025.116703_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.trac.2023.117148","article-title":"Hydrophilic interaction liquid chromatography promotes the development of bio-separation and bio-analytical chemistry","volume":"165","author":"Sheng","year":"2023","journal-title":"TrAC Trends Anal. Chem."},{"key":"10.1016\/j.jpba.2025.116703_bib16","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jchromb.2016.03.020","volume":"1020","author":"Abdallah","year":"2016","journal-title":"J. Chromatogr. B"},{"issue":"30","key":"10.1016\/j.jpba.2025.116703_bib17","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1016\/j.jchromb.2011.09.046","article-title":"Quantification of nicotine, cotinine, trans-3\u2032-hydroxycotinine and varenicline in human plasma by a sensitive and specific UPLC\u2013tandem mass-spectrometry procedure for a clinical study on smoking cessation","volume":"879","author":"Dobrinas","year":"2011","journal-title":"J. Chromatogr. B"},{"issue":"5","key":"10.1016\/j.jpba.2025.116703_bib18","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/fcp.12132","article-title":"Nicotine and metabolites determination in human plasma by ultra performance liquid chromatography\u2013tandem mass spectrometry: a simple approach for solving contamination problem and clinical application","volume":"29","author":"Liachenko","year":"2015","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.jpba.2025.116703_bib19","article-title":"Assessment of nicotine delivery and uptake in users of various tobacco\/nicotine products","volume":"3","author":"Scherer","year":"2022","journal-title":"Curr. Res. Toxicol."},{"key":"10.1016\/j.jpba.2025.116703_bib20","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jchromb.2013.03.032","article-title":"Simultaneous serum nicotine, cotinine, and trans-3\u2032-hydroxycotinine quantitation with minimal sample volume for tobacco exposure status of solid organ transplant patients","volume":"928","author":"Shu","year":"2013","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2025.116703_bib21","unstructured":"FDA, Bioanalytical Method Validation Guidance for Industry, 2018."},{"key":"10.1016\/j.jpba.2025.116703_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2021.122736","article-title":"Rapid, sensitive, and reliable quantitation of nicotine and its main metabolites cotinine and trans-3\u2032-hydroxycotinine by LC-MS\/MS: method development and validation for human plasma","volume":"1179","author":"Mallock","year":"2021","journal-title":"J. Chromatogr. B"},{"issue":"11-12","key":"10.1016\/j.jpba.2025.116703_bib23","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.cca.2012.02.017","article-title":"Simultaneous quantification of nicotine, cotinine, trans-3\u2032-hydroxycotinine, norcotinine and mecamylamine in human urine by liquid chromatography-tandem mass spectrometry","volume":"413","author":"Scheidweiler","year":"2012","journal-title":"Clin. Chim. Acta"},{"issue":"3-4","key":"10.1016\/j.jpba.2025.116703_bib24","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jchromb.2010.12.012","volume":"879","author":"Jacob","year":"2011","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"issue":"4","key":"10.1016\/j.jpba.2025.116703_bib25","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S0731-7085(00)00343-5","article-title":"Simultaneous determination of mecamylamine, nicotine, and cotinine in plasma by gas chromatography-mass spectrometry","volume":"23","author":"Jacob","year":"2000","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"3","key":"10.1016\/j.jpba.2025.116703_bib26","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/add.13183","article-title":"Nicotine delivery, retention and pharmacokinetics from various electronic cigarettes","volume":"111","author":"St Helen","year":"2016","journal-title":"Addiction"},{"key":"10.1016\/j.jpba.2025.116703_bib27","doi-asserted-by":"crossref","DOI":"10.1093\/ntr\/ntae074","article-title":"Pharmacokinetics and pharmacodynamics of inhaled nicotine salt and free-base using an e-cigarette: a randomized crossover study","author":"Christen","year":"2024","journal-title":"Nicotine Tob. Res."},{"issue":"3","key":"10.1016\/j.jpba.2025.116703_bib28","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1007\/s00216-021-03762-1","article-title":"Development and validation of an LC\u2013MS\/MS method for the quantitation of 30 legacy and emerging per- and polyfluoroalkyl substances (PFASs) in human plasma, including HFPO-DA, DONA, and cC6O4","volume":"414","author":"Frigerio","year":"2022","journal-title":"Anal. Bioanal. Chem."},{"issue":"2","key":"10.1016\/j.jpba.2025.116703_bib29","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S1570-0232(02)00914-5","article-title":"Optimization of protein precipitation based upon effectiveness of protein removal and ionization effect in liquid chromatography-tandem mass spectrometry","volume":"785","author":"Polson","year":"2003","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"issue":"2","key":"10.1016\/j.jpba.2025.116703_bib30","doi-asserted-by":"crossref","first-page":"141","DOI":"10.11613\/BM.2015.015","article-title":"Understanding Bland Altman analysis","volume":"25","author":"Giavarina","year":"2015","journal-title":"Biochem. Med."},{"key":"10.1016\/j.jpba.2025.116703_bib31","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jchromb.2017.11.022","article-title":"A simple and highly sensitive UPLC-ESI-MS\/MS method for the simultaneous quantification of nicotine, cotinine, and the tobacco-specific carcinogens N\u2019-nitrosonornicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in serum samples","volume":"1072","author":"Loukotkov\u00e1","year":"2018","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2025.116703_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2022.123534","article-title":"Liquid chromatography\u2013tandem mass spectrometry method for the bioanalysis of N,N-dimethyltryptamine (DMT) and its metabolites DMT-N-oxide and indole-3-acetic acid in human plasma","volume":"1213","author":"Luethi","year":"2022","journal-title":"J. Chromatogr. B"},{"issue":"3","key":"10.1016\/j.jpba.2025.116703_bib33","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s11481-016-9656-y","article-title":"Precision medicine for tobacco dependence: development and validation of the nicotine metabolite ratio","volume":"11","author":"Allenby","year":"2016","journal-title":"J. Neuroimmune Pharm."},{"issue":"4","key":"10.1016\/j.jpba.2025.116703_bib34","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1158\/1055-9965.EPI-19-0644","article-title":"Relationships between the nicotine metabolite ratio and a panel of exposure and effect biomarkers: findings from two studies of U.S. commercial cigarette smokers","volume":"29","author":"Carroll","year":"2020","journal-title":"Cancer Epidemiol. Biomark. Prev."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708525000445?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708525000445?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T15:44:42Z","timestamp":1763999082000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708525000445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":34,"alternative-id":["S0731708525000445"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2025.116703","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A validated single-step saliva and serum sample extraction LC-MS\/MS method for the analysis of nicotine, cotinine and 3\u2019-hydroxycotinine for clinical vaping studies","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2025.116703","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"116703"}}